STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $310,000 | -15.1% | 36,208 | +6.0% | 0.01% | -16.7% |
| Q4 2016 | $365,000 | +162.6% | 34,153 | +166.9% | 0.01% | +200.0% |
| Q3 2016 | $139,000 | +101.4% | 12,796 | +26.3% | 0.00% | +100.0% |
| Q2 2016 | $69,000 | -26.6% | 10,133 | -50.0% | 0.00% | +100.0% |
| Q1 2016 | $94,000 | +44.6% | 20,266 | +97.2% | 0.00% | -50.0% |
| Q4 2015 | $65,000 | -45.8% | 10,275 | -24.7% | 0.00% | -33.3% |
| Q3 2015 | $120,000 | -25.5% | 13,641 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $161,000 | -18.3% | 13,641 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $197,000 | -9.6% | 13,641 | +6.8% | 0.00% | -20.0% |
| Q4 2014 | $218,000 | +24.6% | 12,771 | -9.0% | 0.01% | 0.0% |
| Q3 2014 | $175,000 | – | 14,028 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
| Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
| EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
| Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
| Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
| Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
| SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
| Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |